Sec Form 4 Filing - Bowen Robert @ ABIOMED INC - 2013-06-04

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Bowen Robert
2. Issuer Name and Ticker or Trading Symbol
ABIOMED INC [ ABMD]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Chief Financial Officer
(Last) (First) (Middle)
C/O ABIOMED, INC, 22 CHERRY HILL DR
3. Date of Earliest Transaction (MM/DD/YY)
06/04/2013
(Street)
DANVERS, MA01923
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $.01 par value 06/04/2013 S( 3 ) 5,298 D $ 21.1997 66,929 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) ( 1 ) $ 15.92 12/22/2009( 2 ) 12/22/2018 Common Stock 100,000 100,000 D
Stock Option (right to buy) ( 1 ) $ 5.86 05/28/2010( 2 ) 05/28/2019 Common Stock 2,715 42,285 D
Stock Option (right to buy) ( 1 ) $ 5.86 03/31/2010( 2 ) 05/28/2019 Common Stock 30,000 30,000 D
Stock Option (right to buy) ( 1 ) $ 10.03 06/03/2011( 2 ) 06/03/2020 Common Stock 15,000 15,000 D
Stock Option (right to buy) ( 1 ) $ 22.44 05/22/2013( 2 ) 05/22/2022 Common Stock 20,000 20,000 D
Stock Option (Right to Buy) ( 1 ) $ 23.15 05/14/2014( 2 ) 05/14/2024 Common Stock 20,000 20,000 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Bowen Robert
C/O ABIOMED, INC
22 CHERRY HILL DR
DANVERS, MA01923
Chief Financial Officer
Signatures
/s/ Ian W. McLeod (by power of attorney) 06/06/2013
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
( 2 )These options become exerciseable in annual 25% increments, commencing on the date set forth in Table II, Column 6.
( 3 )Sale of common stock pursuant to reporting owner's 10b5-1 plan. Sold to pay tax obligations upon vesting.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.